These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6139072)

  • 41. [Cholangiographic agents in chronic liver diseases: Can toxic liver cell damages be caused by jodoxamid?].
    Ordnung W; Müting D
    Med Klin; 1979 Feb; 74(5):149-53. PubMed ID: 581694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].
    Kölling K; Hoenle R; Korsten FW
    Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ioversol clinical safety summary.
    Benamor M; Aten EM; McElvany KD; Lankin DG; James MA; Buy-Gandal T; Harashe LT; Weinandt WJ
    Invest Radiol; 1989 Jun; 24 Suppl 1():S67-72. PubMed ID: 2687200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Energy-dependent effect of iodized contrast medium on radiation-induced chromosome aberrations.
    Hadnagy W; Bäuml A; Stephan G
    Radiat Environ Biophys; 1985; 24(1):71-4. PubMed ID: 3975352
    [No Abstract]   [Full Text] [Related]  

  • 45. The risk liability of nephrotropic contrast media: clinical and experimental results.
    Kröpelin T; Gospos C; Papacaralampous X; Freudenberg N
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():129-42. PubMed ID: 6139068
    [No Abstract]   [Full Text] [Related]  

  • 46. Contrast enhanced brain CT. Comparison between iohexol and metrizoate.
    Holtås S; Cronqvist S; Renaa T
    Neuroradiology; 1983; 24(4):213-5. PubMed ID: 6828237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular side effects of various conventional, low-osmolar and non-ionic contrast media.
    Wink K; Wissert J
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():120-4. PubMed ID: 6139066
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral contrast media in paediatrics.
    Healey T
    Clin Radiol; 1984 Jan; 35(1):84. PubMed ID: 6690188
    [No Abstract]   [Full Text] [Related]  

  • 49. [Transient hypothyroidism following administration of roentgen contrast media to the newborn and infants].
    Röhner G; Rautenburg HW
    Med Welt; 1983 Jun; 34(23):668-70. PubMed ID: 6877078
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
    Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
    [No Abstract]   [Full Text] [Related]  

  • 51. Tolerability of iohexol after injection into healthy volunteers.
    Levorstad K; Kolbenstvedt A; Kolmannskog F; Sommerfelt SC; Stormorken H; Andrew E; Sveen K
    Acta Radiol Diagn (Stockh); 1983; 24(3):241-51. PubMed ID: 6624528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Endomirabil, a new contrast medium for the biliary tract. Rate of adverse effects with special reference to the application time].
    Barner L; Kurzen S
    Med Welt; 1977 Apr; 28(17):817-9. PubMed ID: 577589
    [No Abstract]   [Full Text] [Related]  

  • 53. Ascending lower limb phlebography: comparison of ioversol and iothalamate meglumine.
    Wilson AJ; Murphy WA; Destouet JM; Gilula LA; Hardy DC; Monsees B; Totty WG
    Can Assoc Radiol J; 1989 Jun; 40(3):142-4. PubMed ID: 2660958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A comparison of the occurrence of side-effects of ioxaglinic acid (Hexabrix) and metrizoate (Isopaque Amin) in hysterosalpingography. A randomized prospective study].
    Lauridsen KN
    Ugeskr Laeger; 1986 May; 148(19):1141-3. PubMed ID: 3523907
    [No Abstract]   [Full Text] [Related]  

  • 55. Experiences with rayvist and iopromid in head and body CT.
    Zeitler E; Böhnlein K; Gailer H; Lindner R; Richter EI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():162-72. PubMed ID: 6139073
    [No Abstract]   [Full Text] [Related]  

  • 56. A double-blind comparative study of the tolerance of sodium and meglumine ioxaglate (Hexabrix) with meglumine iothalamate (Conray) in ascending phlebography of the leg.
    Thomas ML; Walters HL; Briggs GM
    Australas Radiol; 1982 Nov; 26(3):288-90. PubMed ID: 7165617
    [No Abstract]   [Full Text] [Related]  

  • 57. Iodine-based contrast agents.
    Todd B
    Geriatr Nurs; 1987; 8(6):341-2, 348. PubMed ID: 3692327
    [No Abstract]   [Full Text] [Related]  

  • 58. [Arthrography with Hexabrix--report of experiences].
    Tenner R
    Rontgenblatter; 1985 Aug; 38(8):261-2. PubMed ID: 4059813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical survey on adverse reactions of the contrast media].
    Katayama H; Ikenaka T; Ishida O; Kohno M; Takashima T; Takahashi H; Tada S; Tanaka T; Hachiya J; Hiramatsu K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Sep; 45(9):1198-205. PubMed ID: 4094889
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experiment compared between iodoxamidic acid and ioglycamic acid, in flasks drop by drop. Observations of adverse reactions].
    Viviani G; Mozzanica C; Pozzoli P
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():548. PubMed ID: 1243924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.